Last reviewed · How we verify
Lovaza
At a glance
| Generic name | Lovaza |
|---|---|
| Also known as | omega-3-acid ethyl esters, Omega-3 fatty acid, Omacor (omega-3-acid ethyl esters) capsules, Omega-3-Acid Ethyl Esters, omega three fatty acids |
| Sponsor | ImmunityBio, Inc. |
| Modality | Small molecule |
| Therapeutic area | Other |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Low Dose Tamoxifen With or Without Omega-3 Fatty Acids for Breast Cancer Risk Reduction (PHASE2)
- The Effect of Omega 3 Supplementation on Postoperative Delirium in Elderly Patients Undergoing Major Cardiac Surgery (PHASE2)
- Phase II Trial to Modulate Intermediate Endpoint Biomarkers in Former and Current Smokers (PHASE2)
- Effects of Fish Oil and Red Wine on Oxidative Stress Biomarkers (NA)
- VITamin D and OmegA-3 TriaL: Effects on Bone Structure and Architecture (VITAL) (NA)
- VITamin D and OmegA-3 TriaL (VITAL): Fractures, Vitamin D and Genetic Markers (NA)
- VITamin D and OmegA-3 TriaL: Interrelationship of Vitamin D and Vitamin K on Bone (VITAL) (NA)
- Vitamin D and Omega-3 Hypertension Trial (VITAL Hypertension) (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |